A. Pratt and J. Isaacs, Seronegative rheumatoid arthritis: Pathogenetic and therapeutic aspects, Best Practice & Research Clinical Rheumatology, vol.28, issue.4, pp.651-660
DOI : 10.1016/j.berh.2014.10.016

K. Nishimura, D. Sugiyama, Y. Kogata, G. Tsuji, T. Nakazawa et al., Meta-analysis: Diagnostic Accuracy of Anti???Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis, Annals of Internal Medicine, vol.146, issue.11, pp.797-808, 2007.
DOI : 10.7326/0003-4819-146-11-200706050-00008

A. Willemze, L. Trouw, R. Toes, and T. Huizinga, The influence of ACPA status and characteristics on the course of RA, Nature Reviews Rheumatology, vol.69, issue.3, pp.144-52, 2012.
DOI : 10.1038/nrrheum.2011.204

H. Kallberg, L. Padyukov, R. Plenge, J. Ronnelid, P. Gregersen et al., Gene-Gene and Gene-Environment Interactions Involving HLA-DRB1, PTPN22, and Smoking in Two Subsets of Rheumatoid Arthritis, The American Journal of Human Genetics, vol.80, issue.5, 2007.
DOI : 10.1086/516736

J. Shi, R. Knevel, P. Suwannalai, M. Van-der-linden, G. Janssen et al., Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage, Proceedings of the National Academy of Sciences, vol.108, issue.42, pp.17372-17379, 2011.
DOI : 10.1073/pnas.1114465108

R. Gan, L. Trouw, J. Shi, R. Toes, T. Huizinga et al., Anticarbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis, J Rheumatol. 2015, vol.42, issue.4, pp.572-581

A. Yee, T. Webb, A. Seaman, M. Infantino, F. Meacci et al., Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis, Immunologic Research, vol.10, issue.1-2, pp.24-30, 2015.
DOI : 10.1007/s12026-014-8560-x

X. Jiang, L. Trouw, T. Van-wesemael, J. Shi, C. Bengtsson et al., Anti- CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies Anticarbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage, Ann Rheum Dis. Arthritis Res Ther, vol.7317, issue.101, pp.1761-1769, 2014.

Y. Alamanos and A. Drosos, Epidemiology of adult rheumatoid arthritis, Autoimmunity Reviews, vol.4, issue.3, pp.130-136, 2005.
DOI : 10.1016/j.autrev.2004.09.002

V. Goëb, F. Jouen, D. Gilbert, L. Loët, X. Tron et al., Diagnostic and prognostic usefulness of antibodies to citrullinated peptides, Joint Bone Spine, vol.76, issue.4, 2009.
DOI : 10.1016/j.jbspin.2008.12.006

C. Zeltz and D. Gullberg, Post-translational modifications of integrin ligands as pathogenic mechanisms in disease, Matrix Biology, vol.40, pp.5-9, 2014.
DOI : 10.1016/j.matbio.2014.08.001

M. Bax, T. Huizinga, R. Toes, A. Young, K. Jayakumar et al., The pathogenic potential of autoreactive antibodies in rheumatoid arthritis Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts, Semin Immunopathol. 2014 Arthritis Rheum, vol.3660, issue.38, pp.313-338, 2009.

D. Boeck-supérieur-goulabchand, R. Batteux, F. Guilpain, and P. , Glycosylation of autoantibodies in autoimmunes diseases]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.746-53, 2008.

G. Pruijn, R. Toes, T. Huizinga, and L. Trouw, Citrullination and carbamylation in the pathophysiology of rheumatoid arthritis New biomarkers in rheumatoid arthritis, Front Immunol. Neth J Med, vol.670, issue.9, pp.392-401, 2012.

J. Shi, P. Van-veelen, M. Mahler, G. Janssen, J. Drijfhout et al., Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies, Autoimmunity Reviews, vol.13, issue.3, pp.225-255, 2014.
DOI : 10.1016/j.autrev.2013.10.008

Z. Wang, S. Nicholls, E. Rodriguez, O. Kummu, S. Hörkkö et al., Protein carbamylation links inflammation, smoking, uremia and atherogenesis, Nature Medicine, vol.17, issue.10, 2007.
DOI : 10.1038/nm1637

J. Avina-zubieta, J. Thomas, M. Sadatsafavi, A. Lehman, and D. Lacaille, Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies, Annals of the Rheumatic Diseases, vol.71, issue.9, pp.1524-1533, 2012.
DOI : 10.1136/annrheumdis-2011-200726

J. Eur, U. Steinbrecher, M. Fisher, J. Witztum, and L. Curtiss, Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine, J Lipid Res, vol.4425, issue.1110, pp.3403-3415, 1984.

S. Turunen, M. Koivula, J. Melkko, E. Alasaarela, P. Lehenkari et al., Different amounts of protein-bound citrulline and homocitrulline in foot joint tissues of a patient with anti-citrullinated protein antibody positive erosive rheumatoid arthritis Is there a link between carbamylation and citrullination in periodontal disease and rheumatoid arthritis? Med Hypotheses, J Transl Med, vol.1184, issue.6, pp.570-576, 2013.

S. Turunen, M. Koivula, L. Risteli, and J. Risteli, Anticitrulline antibodies can be caused by homocitrulline-containing proteins in rabbits, Arthritis & Rheumatism, vol.26, issue.11, pp.3345-52, 2010.
DOI : 10.1002/art.27644

J. Shi, L. Van-de-stadt, E. Levarht, T. Huizinga, D. Hamann et al., Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid REFERENCES 1, 2010.

J. Shi, R. Knevel, P. Suwannalai, M. Van-der-linden, G. Janssen et al., Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage, Proceedings of the National Academy of Sciences, vol.108, issue.42, pp.17372-17379, 2011.
DOI : 10.1073/pnas.1114465108

J. Shi, P. Van-veelen, M. Mahler, G. Janssen, J. Drijfhout et al., Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies, Autoimmunity Reviews, vol.13, issue.3, pp.225-255, 2014.
DOI : 10.1016/j.autrev.2013.10.008

Z. Wang, S. Nicholls, E. Rodriguez, O. Kummu, S. Hörkkö et al., Protein carbamylation links inflammation, smoking, uremia and atherogenesis, Nature Medicine, vol.17, issue.10, 2007.
DOI : 10.1038/nm1637

G. Pruijn, Citrullination and Carbamylation in the Pathophysiology of Rheumatoid Arthritis, Frontiers in Immunology, vol.6, p.192, 2015.
DOI : 10.3389/fimmu.2015.00192

A. Yee, T. Webb, A. Seaman, M. Infantino, F. Meacci et al., Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis, Immunologic Research, vol.10, issue.1-2, pp.24-30, 2015.
DOI : 10.1007/s12026-014-8560-x

X. Jiang, L. Trouw, T. Van-wesemael, J. Shi, C. Bengtsson et al., Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies, Annals of the Rheumatic Diseases, vol.72, issue.(Suppl 2), pp.1761-1769, 2014.
DOI : 10.1136/annrheumdis-2013-205109

M. Brink, M. Verheul, J. Rönnelid, E. Berglin, R. Holmdahl et al., Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage, Arthritis Research & Therapy, vol.17, issue.1, pp.25-35, 2015.
DOI : 10.1136/annrheumdis-2013-205109

R. Gan, L. Trouw, J. Shi, R. Toes, T. Huizinga et al., Anticarbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis, J Rheumatol. 2015, vol.42, issue.4, pp.572-581

A. Pratt and J. Isaacs, Seronegative rheumatoid arthritis: Pathogenetic and therapeutic aspects, Best Practice & Research Clinical Rheumatology, vol.28, issue.4, pp.651-660
DOI : 10.1016/j.berh.2014.10.016

S. Turunen, M. Koivula, L. Risteli, and J. Risteli, Anticitrulline antibodies can be caused by homocitrulline-containing proteins in rabbits, Arthritis & Rheumatism, vol.26, issue.11, pp.3345-52, 2010.
DOI : 10.1002/art.27644

P. Muller, J. Anink, and J. Shi, Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the " AMC-Senshu " method, Ann Rheum Dis, vol.72, issue.1, pp.148-50, 2013.

V. Goëb, F. Jouen, D. Gilbert, L. Loët, X. Tron et al., Diagnostic and prognostic usefulness of antibodies to citrullinated peptides, Joint Bone Spine, vol.76, issue.4, 2009.
DOI : 10.1016/j.jbspin.2008.12.006

K. Nishimura, D. Sugiyama, Y. Kogata, G. Tsuji, T. Nakazawa et al., Meta-analysis: Diagnostic Accuracy of Anti???Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis, Annals of Internal Medicine, vol.146, issue.11, pp.797-808, 2007.
DOI : 10.7326/0003-4819-146-11-200706050-00008

S. Annexe and . Hippocrate, Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle